Related Experiment Video
Updated: Sep 18, 2025

10:24
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
6.5K
Micro-hydrogel molding-assisted fabrication of a PDMS-based microfluidic concentration-gradient generator for dynamic
Dhruba Dhar1, Jyotirmoy Chatterjee1, Soumen Das1
1School of Medical Sciences and Technology, Indian Institute of Technology Kharagpur Kharagpur India sou@smst.iitkgp.ac.in.
RSC Advances
|June 24, 2025
Summary
Researchers developed a low-cost microfluidic device for dynamic drug testing. This platform mimics physiological conditions, improving the accuracy of drug dose-response analysis for preclinical drug evaluation.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Cell Biology
Background:
- Traditional cell culture platforms use static drug doses and rigid environments, failing to replicate physiological conditions.
- This limits the accuracy of drug dose-response analysis and preclinical drug evaluation.
Purpose of the Study:
- To develop a cost-effective, accessible microfluidic platform for dynamic drug testing.
- To create a system that mimics physiological conditions for improved drug evaluation accuracy.
Main Methods:
- A polydimethylsiloxane (PDMS)-based microfluidic concentration gradient generator (μCGG) was fabricated using a micro-hydrogel molding technique.
- The μCGG features six integrated cell culture chambers with flexible PDMS bases (kPa range).
- A pressure-driven flow design generated stable drug concentration gradients, validated using simulations and spectroscopy with 5-fluorouracil (5-Fu).
Main Results:
- The μCGG platform successfully generated dynamic drug gradients for cell culture.
- MDA-MB-231 breast cancer cells exposed to 5-Fu showed an IC50 of 41 ± 4 μM.
- Results closely matched conventional methods, validating the platform's accuracy.
Conclusions:
- The developed μCGG is a simple, frugal, and scalable microfluidic platform for drug testing.
- It addresses limitations of traditional methods by incorporating dynamic gradients and relevant mechanical environments.
- This platform offers broader adoption potential for preclinical drug evaluation and dose-response assays.

